Compounds > quinuclidines
Page last updated: 2024-08-18

quinuclidines and Carcinoma, Squamous Cell

quinuclidines has been researched along with Carcinoma, Squamous Cell in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hang, W; Jian, YP; Li, DD; Li, YL; Liu, G; Quan, CS; Shen, XF; Sun, QH; Wang, YS; Xu, ZX; Yin, ZX; Zeng, Q; Zhang, YH; Zhao, RX1
Califano, JA; Kang, SK; Koch, WM; Minn, I; Roh, JL; Sidransky, D1
Chambers, MS; Stinnett, S; Witsell, DL1
Hori, H; Kinashi, Y; Maruhashi, A; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Uto, Y1

Trials

1 trial(s) available for quinuclidines and Carcinoma, Squamous Cell

ArticleYear
Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia.
    Head & neck, 2012, Volume: 34, Issue:8

    Topics: Carcinoma, Squamous Cell; Double-Blind Method; Female; Head and Neck Neoplasms; Humans; Male; Muscarinic Agonists; Oral Health; Quality of Life; Quinuclidines; Radiotherapy; Salivary Glands; Severity of Illness Index; Thiophenes; Xerostomia

2012

Other Studies

3 other study(ies) available for quinuclidines and Carcinoma, Squamous Cell

ArticleYear
Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.
    Oncogene, 2018, Volume: 37, Issue:25

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Proliferation; Dioxolanes; Drug Therapy, Combination; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Glutathione S-Transferase pi; Head and Neck Neoplasms; Humans; Male; Mice; Mice, SCID; Prognosis; Quinuclidines; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2018
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma.
    Oral oncology, 2011, Volume: 47, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Drug Screening Assays, Antitumor; Female; Furans; Genetic Therapy; Head and Neck Neoplasms; Humans; Imidazoles; Male; Piperazines; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53

2011
The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2006, Volume: 22, Issue:4

    Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Proliferation; Cell Survival; Combined Modality Therapy; Cyclic N-Oxides; Female; Fluorescent Antibody Technique; Hyperthermia, Induced; Hypoxia; Mice; Mice, Inbred C3H; Micronucleus Tests; Quinoxalines; Quinuclidines; Sulfhydryl Compounds; Time Factors; Tissue Distribution; Tumor Cells, Cultured

2006